The Marked Chart Wire · Business
Viking Therapeutics
Viking Therapeutics misses third quarter earnings estimates
Viking Therapeutics reported a loss of $1.55 per share for the third quarter, missing the expected loss of $1.05. The company's actual results were 47.62 percent worse than analyst projections.
